Concepedia

Naoya Fujino

NF

Statistics

Publications

32

Citations

1.8K

H-Index

26

Active since

2008

Affiliations

Tohoku University(Current)

Tohoku University Hospital

AstraZeneca (Sweden)

Osaki Citizen Hospital

Saitama Medical University

Naoya Fujino is an author at Tohoku University specializing in inflammation, life sciences, and cell biology.

ORCID

Publications per year

2008–2023

32

Publications

32

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

Mei He, Hiroshi Kubo, Konosuke Morimoto et al. · EMBO Reports · 2011 · 226 citations · Full text

, , +12

Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility

Toru Takahashi, Seiichi Kobayashi, Naoya Fujino et al. · Thorax · 2012 · 147 citations · Full text

, , +16

Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis

Tomonori Makiguchi, Mitsuhiro Yamada, Yusuke Yoshioka et al. · Respiratory Research · 2016 · 133 citations · Full text

, , +17

The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung

Takahito Fujimori, Aleksander M. Grabiec, Manminder Kaur et al. · Mucosal Immunology · 2015 · 127 citations · Full text

, , +15

The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells

Mitsuhiro Yamada, Hiroshi Kubo, Chiharu Ota et al. · Respiratory Research · 2013 · 112 citations · Full text

, , +17

1–5 of 32